Log In
person
Biora Therapeutics Inc
BIOR
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Oral Biotherapeutics |
Genetic, Genomic, and Sequencing Kits (outsourced)
These companies outsource the manufacturing of genetic, genomic, and sequencing test kits and sell directly to their customers.
|
305,000 | 100.00% |
| Oral Biotherapeutics |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_down |
Oral Biotherapeutics
Genetic, Genomic, and Sequencing Kits (outsourced)
|
305,000 | 100.00% |
| keyboard_arrow_right |
These companies outsource the manufacturing of genetic, genomic, and sequencing test kits and sell directly to their customers.
|
||
| keyboard_arrow_down |
Oral Biotherapeutics
Pre-Revenue Pharmaceuticals
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||